Modafinil treatment in patients with seasonal affective disorder/winter depression: an open-label pilot study

被引:27
|
作者
Lundt, L [1 ]
机构
[1] Foothills Psychiat, Boise, ID 83702 USA
关键词
modafinil; seasonal affective disorder; winter depression; fatigue; wakefulness;
D O I
10.1016/S0165-0327(03)00162-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Hypersomnia is a cardinal symptom of seasonal affective disorder/winter depression. This open-label pilot study assessed modafinil, a novel wake-promoting agent, as treatment for seasonal affective disorder/winter depression. Methods: Total daily modafinil dose was 100 mg (all patients week 1), and 100 mg or 200 mg split dose (weeks 2-8). Efficacy assessments (weeks 1, 2, 5, and 8) included the Structured Interview Guide for the Hamilton Depression (HAM-D) Rating Scale, Seasonal Affective Disorder Version (SIGH-SAD), Montgomery-Asberg Depression Rating Scale (MADRS), Clinical Global Impression of Change (CGI-C), Fatigue Severity Scale (FSS), and Epworth Sleepiness Scale (ESS). Results: Thirteen patients (11 women; mean age, 41 years) were enrolled, 12 were evaluable for efficacy (100 mg dose, five patients; 200 mg dose, seven patients), and nine completed treatment. Modafinil significantly improved winter depression as shown by reductions from baseline in mean SIGH-SAD at week 1 (P<0.01) through week 8 (P<0.001 weeks 2-8) and MADRS total scores from week 2 through week 8 (P<0.01 for all). At week 8, mean SIGH-SAD total score was 17.1 (versus 37.2 at baseline, P<0.001), and mean MADRS total score was 13.3 (versus 26.9 at baseline, P<0.01). Modafinil significantly improved overall clinical condition at all time points (P<0.001). The response rate was 67% on the SIGH-SAD (29 item), HAM-D (21 item), and MADRS, and 100% on eight atypical SIGH-SAD items. Modafinil significantly reduced fatigue (FSS) and improved wakefulness (ESS) from weeks 2 through 8 (P<0.01). Modafinil was well tolerated. Limitations: This was an open-label, single site study. Conclusions: Modafinil may be an effective and well-tolerated treatment in patients with seasonal affective disorder/winter depression. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:173 / 178
页数:6
相关论文
共 50 条
  • [21] Open-label study of adjunct modafinil for the treatment of patients with fatigue, sleepiness, and major depression treated with selective serotonin reuptake inhibitors
    Numan Konuk
    Nuray Atasoy
    Levent Atik
    Ömer Akay
    Advances in Therapy, 2006, 23 : 646 - 654
  • [22] An open-label extension study of modafinil for the treatment of daytime sleepiness in patients with Parkinson's disease
    Adler, CH
    Caviness, JN
    Hentz, JG
    Lind, M
    Tiede, J
    SLEEP, 2002, 25 : A251 - A252
  • [23] Open-label pilot study of lisdexamfetamine for cocaine use disorder
    Mariani, John J.
    Choi, C. Jean
    Pavlicova, Martina
    Mahony, Amy L.
    Brooks, Daniel J.
    Grabowski, John
    Levin, Frances R.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2021, 47 (03): : 402 - 409
  • [24] Open-label pilot study of adjunctive aripiprazole treatment for difficult to treat bipolar depression
    Metrick, M. S.
    Anand, A.
    BIPOLAR DISORDERS, 2008, 10 : 38 - 38
  • [25] Maintenance use of ketamine for treatment-resistant depression: an open-label pilot study
    Barenboim, Ivan
    Lafer, Beny
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2018, 40 (01) : 110 - 110
  • [26] Dextromethorphan-Quinidine in Treatment-Resistant Depression: An Open-Label Pilot Study
    Wang, Philip
    Yavi, Mani
    Park, Lawrence
    Zarate, Carlos
    BIOLOGICAL PSYCHIATRY, 2023, 93 (09) : S177 - S178
  • [27] Mirtazapine in treatment of adolescents with major depression. An open-label, multicenter pilot study
    Haapasalo-Pesu, KM
    Vuola, T
    Lahdelma, L
    Marttunen, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S198 - S198
  • [28] Effects of modafinil in children with attention-deficit/hyperactivity disorder: An open-label study
    Rugino, TA
    Copley, TC
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2001, 40 (02): : 230 - 235
  • [29] Topiramate in the treatment of trichotillomania: an open-label pilot study
    Lochner, Christine
    Seedat, Soraya
    Niehaus, Dana J. H.
    Stein, Dan J.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (05) : 255 - 259
  • [30] An open-label pilot study of transdermal selegiline for depression in Parkinson's disease patients
    Abhishek, R.
    Eng, M.
    Lyons, K. E.
    Pahwa, R.
    MOVEMENT DISORDERS, 2008, 23 (01) : S304 - S305